Fiche personne
Coordonnées
ICANS | Institut cancérologie Strasbourg Europe
17 rue Albert Calmette
BP 23025
67033 STRASBOURG
03 68 76 73 01
Territoire
Alsace
Statut
Hospitalo-Universitaire
Projets
Séquençage du génome de lymphomes spléniques de la zone marginale (LYMPHOSEQ)
2013 - Porteur du projet : Pr BAHRAM Siamak - Partenaire : Pr FEUGIER Pierre , Pr HERBRECHT Raoul
Validation diagnostic et caractérisation de nouveaux marqueurs des lymphomes de la zone marginale identifiés par bio-informatique et protéomique (MALYZOMA)
2013 - Porteur du projet : Pr MAUVIEUX Laurent - Partenaire : Pr CHENARD Marie-Pierre , Dr CIANFERANI Sarah , Pr FEUGIER Pierre , Pr HERBRECHT Raoul , Dr HOULGATTE Rémy , Dr LESESVE Jean-François , Pr PLENAT François
Publications
Artificial intelligence-based flow cytometry for the diagnosis of B-cell chronic lymphoproliferative disorders.
Mauvieux L, Herbrecht R, Eischen A, Galoisy AC, Rolland D, Gervais C, Mayeur-Rousse C, Hueber-Bonnot S, Nicolae A, Fornecker LM, Goetsch T, Severac F, Bizoï R, Fabacher T, Miguet L
Blood Adv. 2025 11 25;9(22):5880-5887
Features of Invasive Aspergillosis Caused by Aspergillus flavus, France, 2012-2018.
Bertin-Biasutto L, Paccoud O, Garcia-Hermoso D, Denis B, Boukris-Sitbon K, Lortholary O, Bretagne S, Gits-Muselli M, Herbrecht R, Letscher-Bru V, Danion F, Cassaing S, Morio F, Nourrisson C, Pihet M, Sasso M, Desoubeaux G, Durieux MF, Bonhomme J, Chachaty E, Chouaki T, Desbois-Nogard N, Alanio A, Gangneux JP, Lanternier F
Emerg Infect Dis. 2025 05;31(5):896-905
Effectiveness, Safety, and Patterns of Real-World Isavuconazole Use in Europe (2015-2019).
Neofytos D, Pagliuca A, Houghton K, Broughton E, de Figueiredo Valente MLN, Jiang L, Enoch DA, Gruener B, Herbrecht R, Lahmer T, Lortholary O, Melenotte C, De Rosa FG, Garcia-Vidal C, Jimenez M, Fernandez M, Cornely O
Infect Dis Ther. 2024 10 24;:
Is there an interest in systematic serum screening for aspergillosis in COVID-19 patients in a medical ward?
Gerber V, Boehn L, Sabou M, Studer A, Ursenbach A, Hansmann Y, Herbrecht R, Lefebvre N, Letscher-Bru V, Danion F
Infect Dis Now. 2024 04 16;:104918
, and Other Rare Mold Invasive Infections: Over Twenty-Five-Year Experience of a European Tertiary-Care Center.
Ledoux MP, Dicop E, Sabou M, Letscher-Bru V, Castelain V, Danion F, Herbrecht R
J Fungi (Basel). 2024 04 15;10(4):
Normal B cells express ZAP70 in chronic lymphocytic leukemia: A link between autoimmunity and lymphoproliferation?
Ghergus D, Martin M, Knapp AM, Delmotte F, Joublin-Delavat A, Jung S, Schickel JN, Mendel I, Dupuis A, Drénou B, Ghesquières H, Salles G, Baseggio L, Herbrecht R, Korganow AS, Vallat L, Soulas-Sprauel P, Meffre E, Martin T
Am J Hematol. 2023 10 19;:
Improving diagnosis of pulmonary mucormycosis: leads from a contemporary national study of 114 cases.
Coste A, Conrad A, Porcher R, Poirée S, Peterlin P, Defrance C, Letscher-Bru V, Morio F, Gastinne T, Bougnoux ME, Suarez F, Nevez G, Dupont D, Ader F, Halfon-Domenech C, Ducastelle-Leprêtre S, Botterel F, Millon L, Guillerm G, Ansart S, Boutoille D, Ledoux MP, Herbrecht JE, Robin C, Melica G, Danion F, Blanchard E, Paccoud O, Garcia-Hermoso D, Lortholary O, Herbrecht R, Lanternier F,
Chest. 2023 07 5;:
Systemic antifungal strategies in allogeneic hematopoietic stem cell recipients hospitalized in french hematology units: a post-hoc analysis of the cross-sectional observational AFHEM study.
Michallet M, Cheikh JE, Herbrecht R, Yakoub-Agha I, Caillot D, Gangneux JP
BMC Infect Dis. 2022 Apr 9;22(1):352
Infectious complications of targeted drugs and biotherapies in acute leukemia. Clinical practice guidelines by the European Conference on Infections in Leukemia (ECIL), a joint venture of the European Group for Blood and Marrow Transplantation (EBMT), the
Maschmeyer G, Bullinger L, Garcia-Vidal C, Herbrecht R, Maertens J, Menna P, Pagano L, Thiebaut-Bertrand A, Calandra T
Leukemia. 2022 Apr 2;:
Evaluation of serum Mucorales PCR for the diagnosis of Mucormycoses: The MODIMUCOR prospective trial.
Millon L, Caillot D, Berceanu A, Bretagne S, Lanternier F, Morio F, Letscher-Bru V, Dalle F, Denis B, Alanio A, Boutoille D, Bougnoux ME, Botterel F, Chouaki T, Charbonnier A, Ader F, Dupont D, Bellanger AP, Rocchi S, Scherer E, Gbaguidi-Haore H, Herbrecht R
Clin Infect Dis. 2022 Jan 5;:
Fungal Infections Caused by Kazachstania spp., Strasbourg, France, 2007-2020.
Kaeuffer C, Baldacini M, Ruge T, Ruch Y, Zhu YJ, De Cian M, Philouze G, Bachellier P, Denis J, Lefebvre N, Schneider F, Hansmann Y, Letscher-Bru V, Herbrecht R, Sabou M, Danion F
Emerg Infect Dis. 2022 Jan;28(1):29-34
Cerebral aspergillosis in the era of new antifungals: the CEREALS national cohort study Nationwide CEREbral Aspergillosis Lesional study (CEREALS).
Serris A, Benzakoun J, Danion F, Porcher R, Sonneville R, Wolff M, Kremer S, Letscher-Bru V, Fekkar A, Hekimian G, Pourcher V, Bougnoux ME, Poirée S, Ader F, Persat F, Cotton F, Tattevin P, Gangneux JP, Lelièvre L, Cassaing S, Bonneville F, Houze S, Bretagne S, Herbrecht R, Lortholary O, Naggara O, Lanternier F,
J Infect. 2021 Nov 24;:
Pregnancy outcome in women with transfused beta-thalassemia in France.
Virot E, Thuret I, Jardel S, Herbrecht R, Lachenal F, Lionnet F, Lucchini MJ, Machin J, Nimubona S, Ribeil JA, Galacteros F, Cannas G, Hot A
Ann Hematol. 2021 Oct 20;:
COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA).
Pagano L, Salmanton-García J, Marchesi F, Busca A, Corradini P, Hoenigl M, Klimko N, Koehler P, Pagliuca A, Passamonti F, Verga L, Víšek B, Ilhan O, Nadali G, Weinbergerová B, Córdoba-Mascuñano R, Marchetti M, Collins GP, Farina F, Cattaneo C, Cabirta A, Gomes-Silva M, Itri F, van Doesum J, Ledoux MP, Čerňan M, Jakšić O, Duarte RF, Magliano G, Omrani AS, Fracchiolla NS, Kulasekararaj A, Valković T, Poulsen CB, Machado M, Glenthøj A, Stoma I, Ráčil Z, Piukovics K, Navrátil M, Emarah Z, Sili U, Maertens J, Blennow O, Bergantim R, García-Vidal C, Prezioso L, Guidetti A, Del Principe MI, Popova M, de Jonge N, Ormazabal-Vélez I, Fernández N, Falces-Romero I, Cuccaro A, Meers S, Buquicchio C, Antić D, Al-Khabori M, García-Sanz R, Biernat MM, Tisi MC, Sal E, Rahimli L, Čolović N, Schönlein M, Calbacho M, Tascini C, Miranda-Castillo C, Khanna N, Méndez GA, Petzer V, Novák J, Besson C, Duléry R, Lamure S, Nucci M, Zambrotta G, Žák P, Seval GC, Bonuomo V, Mayer J, López-García A, Sacchi MV, Booth S, Ciceri F, Oberti M, Salvini M, Izuzquiza M, Nunes-Rodrigues R, Ammatuna E, Obr A, Herbrecht R, Núñez-Martín-Buitrago L, Mancini V, Shwaylia H, Sciumè M, Essame J, Nygaard M, Batinić J, Gonzaga Y, Regalado-Artamendi I, Karlsson LK, Shapetska M, Hanakova M, El-Ashwah S, Borbényi Z, Çolak GM, Nordlander A, Dragonetti G, Maraglino AME, Rinaldi A, De Ramón-Sánchez C, Cornely OA,
J Hematol Oncol. 2021 10 14;14(1):168
Poly(ADP-ribose)polymerase inhibitors-associated myeloid neoplasms: a retrospective study from the French Network of Pharmacovigilance centres.
Morice PM, Genthon A, Boyer T, Bihan K, Mahé J, Sourisseau A, Peyrouzet H, Miremont G, Lepelley M, Stefani L, Gaboriau L, Rocher F, Aquaronne D, Le Beller C, Allouchery M, Azzouz B, Massy N, Alt-Tebacher M, Simand C, Herbrecht R, Chrétien B, Dolladille C, Chantepie S, Alexandre J
Br J Haematol. 2021 Oct 5;:
Cerebral mucormycosis: neuroimaging findings and histopathological correlation.
Lersy F, Royer-Leblond J, Lhermitte B, Chammas A, Schneider F, Hansmann Y, Lefebvre N, Denis J, Sabou M, Lafitte F, Cotton F, Boncoeur-Martel MP, Tourdias T, Pruvo JP, Cottier JP, Herbrecht R, Kremer S
J Neurol. 2021 Jul 8;:
Temporal multiomic modeling reveals a B-cell receptor proliferative program in chronic lymphocytic leukemia.
Schleiss C, Carapito R, Fornecker LM, Muller L, Paul N, Tahar O, Pichot A, Tavian M, Nicolae A, Miguet L, Mauvieux L, Herbrecht R, Cianferani S, Freund JN, Carapito C, Maumy-Bertrand M, Bahram S, Bertrand F, Vallat L
Leukemia. 2021 Apr 8;:
Factors associated with coinfections in invasive aspergillosis: a retrospective cohort study.
Danion F, Duval C, Séverac F, Bachellier P, Candolfi E, Castelain V, Clere-Jehl R, Denis J, Dillenseger L, Epailly E, Gantzer J, Guffroy B, Hansmann Y, Herbrecht JE, Letscher-Bru V, Leyendecker P, Le Van Quyen P, Ludes PO, Morel G, Moulin B, Paillard C, Renaud-Picard B, Roche AC, Sabou M, Schneider F, Solis M, Talagrand-Reboul E, Veillon F, Ledoux MP, Simand C, Herbrecht R
Clin Microbiol Infect. 2021 Mar 1;:
Antifungal Stewardship in Hematology: Reflection of a Multidisciplinary Group of Experts.
Michallet M, Sobh M, Deray G, Gangneux JP, Pigneux A, Larrey D, Ribaud P, Mira JP, Nivoix Y, Yakoub-Agha I, Timsit JF, Alfandari S, Herbrecht R
Clin Lymphoma Myeloma Leuk. 2020 Aug 18;:
Needles in a haystack: Extremely rare invasive fungal infections reported in FungiScope® - Global Registry for Emerging Fungal Infections.
Salmanton-GarcÍa J, Koehler P, Kindo A, Falces-Romero I, GarcÍa-RodrÍguez J, RÁČil Z, Chen SC, Klimko N, Desoubeaux G, Thompson IGR, BenÍtez-PeÑuela MÁ, RodrÍguez JY, Sheppard DC, Hoenigl M, Govic YL, Badali H, Baddley JW, Chander J, Ingram PR, Pakstis DL, Mellinghoff SC, Atici S, Cesaro S, Chakrabarti A, Dupont D, GonzÁlez GM, Hatvani L, Herbrecht R, Klyasova G, Lass-FlÖrl C, Mares M, Mullane K, Vinh DC, Wisplinghoff H, Lackner M, Cornely OA, Seidel D,
J. Infect.. 2020 Aug 13;:
Real-world non-interventional long-term post-authorisation safety study of ruxolitinib in myelofibrosis.
Barraco F, Greil R, Herbrecht R, Schmidt B, Reiter A, Willenbacher W, Raymakers R, Liersch R, Wroclawska M, Pack R, Burock K, Karumanchi D, Gisslinger H
Br. J. Haematol.. 2020 Jun 24;:
Incidental Discovery of a COVID-19 Infection on a Reevaluation FDG PET/CT in a Patient Treated for Hodgkin Lymphoma.
Simand C, Bund C, Guffroy B, Chaban V, Herbrecht R
Clin Nucl Med. 2020 Jun 8;:
Concomitant hemorrhagic syndrome and recurrent extensive arterial thrombosis in a patient with COVID-19 and acute promyelocytic leukemia.
Baldacini M, Pop R, Sattler L, Mauvieux L, Bilger K, Gantzer J, Schneider F, Beaujeux R, Simand C, Herbrecht R
Br. J. Haematol.. 2020 May 5;:
Severe Neutropenia and Agranulocytosis Related to Antithyroid Drugs: A Study of 30 Cases Managed in A Single Reference Center.
Andrès E, Lorenzo Villalba N, Mourot-Cottet R, Maloisel F, Tebacher M, Gottenberg JE, Goichot B, Herbrecht R, Zulfiqar AA
Medicines (Basel). 2020 Mar 19;7(3):
Validation by real-life data of the new radiological criteria of the revised and updated consensus definition for invasive fungal diseases.
Herbrecht R, Guffroy B, Danion F, Venkatasamy A, Simand C, Ledoux MP
Clin. Infect. Dis.. 2020 Mar 2;:
Clinical Characteristics and Outcomes of invasive Lomentospora prolificans Infections: Analysis of Patients in the FungiScope® Registry.
Jenks JD, Seidel D, Cornely OA, Chen S, van Hal S, Kauffman C, Miceli MH, Heinemann M, Christner M, Jover Sáenz A, Burchardt A, Kemmerling B, Herbrecht R, Steinmann J, Shoham S, Gräber S, Pagano L, Deeren D, Slavin MA, Hoenigl M
Mycoses. 2020 Feb 21;:
Invasive Pulmonary Aspergillosis treatment duration in haematology patients in Europe: an EFISG, IDWP-EBMT, EORTC-IDG, SEIFEM survey.
Lanternier F, Seidel D, Pagano L, Styczynski J, Mikulska M, Pulcini C, Maertens J, Munoz P, Garcia C, Rijnders B, Arendrup MC, Sabino R, Verissimo C, Gaustad P, Klimko N, Arikan-Akdagli S, Arsic V, Barac A, Skiada A, Klingspor L, Herbrecht R, Donnelly P, Cornely OA, Lass-Flörl C, Lortholary O
Mycoses. 2020 Feb 3;:
Antifungal Therapy: New and Evolving Therapies.
Nivoix Y, Ledoux MP, Herbrecht R
Semin Respir Crit Care Med. 2020 Feb;41(1):158-174
Invasive Pulmonary Aspergillosis.
Ledoux MP, Guffroy B, Nivoix Y, Simand C, Herbrecht R
Semin Respir Crit Care Med. 2020 Feb;41(1):80-98
Voriconazole plus terbinafine combination antifungal therapy for invasive Lomentospora prolificans infections: analysis of 41 patients from the FungiScope® registry 2008-2019.
Jenks JD, Seidel D, Cornely OA, Chen S, van Hal S, Kauffman C, Miceli MH, Heinemann M, Christner M, Sáenz AJ, Burchardt A, Kemmerling B, Herbrecht R, Steinmann J, Shoham S, Gräber S, Pagano L, Deeren D, Aslam S, Taplitz R, Revankar SG, Baddley J, Mehta SR, Reed S, Slavin MA, Hoenigl M
Clin. Microbiol. Infect.. 2020 Jan 20;:
Invasive Scedosporium spp. and Lomentospora prolificans Infections in Pediatric Patients: Analysis of 55 Cases from FungiScope® and the Literature.
Seidel D, Hassler A, Salmanton-García J, Koehler P, Mellinghoff SC, Carlesse F, Cheng MP, Falces-Romero I, Herbrecht R, Jover Sáenz A, Klimko N, Mareș M, Lass-Floerl C, Soler-Palacín P, Wisplinghoff H, Cornely OA, Pana Z, Lehrnbecher T
Int. J. Infect. Dis.. 2019 Dec 18;:
Risk factors and mortality in invasive Rasamsonia spp. infection: Analysis of cases in the FungiScope® registry and from the literature.
Stemler J, Salmanton-García J, Seidel D, Alexander B, Bertz H, Hoenigl M, Herbrecht R, Meintker L, Meißner A, Mellinghoff SC, Sal E, Zarrouk M, Koehler P, Cornely OA
Mycoses. 2019 Nov 26;:
Amotosalen-inactivated fresh frozen plasma is comparable to solvent-detergent inactivated plasma to treat thrombotic thrombocytopenic purpura.
Garraud O, Malot S, Herbrecht R, Ojeda-Uribe M, Lin JS, Veyradier A, Payrat JM, Liu K, Corash L, Coppo P
Transfus. Apher. Sci.. 2019 Nov 5;:102665
Using routine blood parameters to anticipate clinical outcomes in invasive aspergillosis.
Pang L, Zhao X, Dickens BL, Lim JT, Cook AR, Netea MG, Donnelly JP, Herbrecht R, Johnson EM, Maertens JA, Kullberg BJ, Troke PF, Marr KA, Chai LYA
Clin. Microbiol. Infect.. 2019 Oct 24;:
Isavuconazole for the treatment of patients with invasive fungal diseases involving the central nervous system.
Schwartz S, Cornely OA, Hamed K, Marty FM, Maertens J, Rahav G, Herbrecht R, Heinz WJ
Med. Mycol.. 2019 Oct 15;:
Methylprednisolone-induced immune thrombocytopenia.
Dubert M, Le Toriellec E, Croisille L, Thomas L, Ducreux M, Froissart A, Herbrecht R, Lebrun-Vignes B, Marolleau JP, Méric JB, Mahevas M, Michel M, Bierling P
Am. J. Hematol.. 2019 Oct 10;:
Matched-paired analysis of patients treated for invasive mucormycosis: standard treatment versus posaconazole new formulations (MoveOn).
Salmanton-García J, Seidel D, Koehler P, Mellinghoff SC, Herbrecht R, Klimko N, Ráčil Z, Falces-Romero I, Ingram P, Benítez-Peñuela MÁ, Rodríguez JY, Desoubeaux G, Barać A, García-Vidal C, Hoenigl M, Mehta SR, Cheng MP, Klyasova G, Heinz WJ, Iqbal N, Krause R, Ostermann H, Penack O, Schalk E, Sheppard DC, Willinger B, Wisplinghoff H, Vehreschild JJ, Cornely OA, Vehreschild MJGT,
J. Antimicrob. Chemother.. 2019 Aug 8;:
Large deletions of the 5' region of IKZF1 lead to haploinsufficiency in B-cell precursor acute lymphoblastic leukaemia.
Morel G, Deau MC, Simand C, Caye-Eude A, Arfeuille C, Ittel A, Miguet L, Mauvieux L, Herbrecht R, Paillard C, Strullu M, Cavé H, Chan S, Kastner P, Heizmann B
Br. J. Haematol.. 2019 May 30;:
Evaluation of mass spectrometry detection of pan-fungal serum disaccharide (MS-DS) for the diagnosis of invasive fungal infections: results from a collaborative study involving six European clinical centres.
Cornu M, Sendid B, Mery A, François N, Malgorzata M, Letscher-Bru V, De Carolis E, Damonti L, Titecat M, Bochud PY, Alanio A, Sanguinetti M, Viscoli C, Herbrecht R, Guerardel Y, Poulain D
J. Clin. Microbiol.. 2019 Feb 20;:
Multi-omics dataset to decipher the complexity of drug resistance in diffuse large B-cell lymphoma.
Fornecker LM, Muller L, Bertrand F, Paul N, Pichot A, Herbrecht R, Chenard MP, Mauvieux L, Vallat L, Bahram S, Cianférani S, Carapito R, Carapito C
Sci Rep. 2019 Jan 29;9(1):895
Micafungin prophylaxis in routine medical practice in adult and pediatric patients with hematological malignancy: a prospective, observational study in France.
El Cheikh J, Ceballos P, Dalle JH, Ducastelle-Leprêtre S, Dulon E, Herbrecht R
Diagn. Microbiol. Infect. Dis.. 2019 Jan 26;:
BCR-associated factors driving chronic lymphocytic leukemia cells proliferation ex vivo.
Schleiss C, Ilias W, Tahar O, Güler Y, Miguet L, Mayeur-Rousse C, Mauvieux L, Fornecker LM, Toussaint E, Herbrecht R, Bertrand F, Maumy-Bertrand M, Martin T, Fournel S, Georgel P, Bahram S, Vallat L
Sci Rep. 2019 Jan 24;9(1):701
Prognostic factors in 264 adults with invasive Scedosporium spp. and Lomentospora prolificans infection reported in the literature and FungiScope®.
Seidel D, Meißner A, Lackner M, Piepenbrock E, Salmanton-García J, Stecher M, Mellinghoff S, Hamprecht A, Durán Graeff L, Köhler P, Cheng MP, Denis J, Chedotal I, Chander J, Pakstis DL, Los-Arcos I, Slavin M, Montagna MT, Caggiano G, Mares M, Trauth J, Aurbach U, Vehreschild MJGT, Vehreschild JJ, Duarte RF, Herbrecht R, Wisplinghoff H, Cornely OA, Bachmann B, Borchert K, Burchardt A, Chakrabarti A, Christopeit M, Fasih N, Hekmat K, Hernández Rupérez B, Kemmerling B, Kessel J, Jyoti Kindo A, Klimko N, Krause R, Lass-Flörl C, Levesque E, Lockhart S, Steinmann J, Maritati A, Markiefka B, Martín Gómez MT, Meis J, Oksi J, Pagano L, Ramos Martinez A, Reischies F, Soler Palacin P, Vermeulen E
Crit. Rev. Microbiol.. 2019 Jan 10;:1-21
Tuberculosis and atypical mycobacterial infections in ruxolitinib treated patients with primary or secondary myelofibrosis or polycythemia vera.
Lescuyer S, Ledoux MP, Gravier S, Natarajan-Amé S, Duval C, Maloisel F, Mauvieux L, Toussaint E, Fornecker LM, Herbrecht R
Int. J. Infect. Dis.. 2019 Jan 10;:
Isavuconazole versus Caspofungin in the Treatment of Candidemia and Other Invasive Candida Infections: The ACTIVE Trial.
Kullberg BJ, Viscoli C, Pappas PG, Vazquez J, Ostrosky-Zeichner L, Rotstein C, Sobel JD, Herbrecht R, Rahav G, Jaruratanasirikul S, Chetchotisakd P, Van Wijngaerden E, De Waele J, Lademacher C, Engelhardt M, Kovanda LL, Croos-Dabrera R, Fredericks C, Thompson GR
Clin. Infect. Dis.. 2018 Oct 5;:
Treatment outcomes in patients with proven/probable versus possible invasive mould disease in a phase III trial comparing isavuconazole versus voriconazole.
Maertens J, Selleslag D, Heinz WJ, Saulay M, Rahav G, Giladi M, Aoun M, Kovanda L, Kaufhold A, Engelhardt M, Cornely OA, Herbrecht R, Ullmann AJ
Mycoses. 2018 Jul 23;:
Systematic review and network meta-analysis of clinical outcomes associated with isavuconazole versus relevant comparators for patients with invasive aspergillosis.
Herbrecht R, Kuessner D, Pooley N, Posthumus J, Escrig C
Curr Med Res Opin. 2018 Jul 19;:1-21
Progression-Free Survival as a Surrogate End Point for Overall Survival in First-Line Diffuse Large B-Cell Lymphoma: An Individual Patient-Level Analysis of Multiple Randomized Trials (SEAL).
Shi Q, Schmitz N, Ou FS, Dixon JG, Cunningham D, Pfreundschuh M, Seymour JF, Jaeger U, Habermann TM, Haioun C, Tilly H, Ghesquieres H, Merli F, Ziepert M, Herbrecht R, Flament J, Fu T, Coiffier B, Flowers CR
J. Clin. Oncol.. 2018 Jul 5;:JCO2018779124
18F-FDG PET/CT for invasive fungal infection in immunocompromised patients.
Leroy-Freschini B, Treglia G, Argemi X, Bund C, Kessler R, Herbrecht R, Imperiale A
QJM. 2018 Jun 18;:
Progression-Free Survival at 24 Months (PFS24) and Subsequent Outcome For Patients With Diffuse Large B-Cell Lymphoma (DLBCL) Enrolled On Randomized Clinical Trials.
Maurer MJ, Habermann TM, Shi Q, Schmitz N, Cunningham D, Pfreundschuh M, Seymour JF, Jaeger U, Haioun C, Tilly H, Ghesquieres H, Merli F, Ziepert M, Herbrecht R, Flament J, Fu T, Flowers CR, Coiffier B
Ann. Oncol.. 2018 Jun 12;:
Systemic Antifungal Prophylaxis in Patients Hospitalized in Hematology Units in France: The AFHEM Cross-Sectional Observational Study.
Gangneux JP, El Cheikh J, Herbrecht R, Yakoub-Agha I, Quiniou JB, Caillot D, Michallet M
Infect Dis Ther. 2018 Jun 9;:
Characterization of efficacy and safety of pathogen inactivated and quarantine plasma in routine use for treatment of acquired immune thrombotic thrombocytopenic purpura.
Herbrecht R, Ojeda-Uribe M, Kientz D, Fohrer C, Bohbot A, Hinschberger O, Liu KL, Remy E, Ernst C, Lin JS, Corash L, Cazenave JP
Vox Sang.. 2018 May 21;:
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline.
Ullmann AJ, Aguado JM, Arikan-Akdagli S, Denning DW, Groll AH, Lagrou K, Lass-Flörl C, Lewis RE, Munoz P, Verweij PE, Warris A, Ader F, Akova M, Arendrup MC, Barnes RA, Beigelman-Aubry C, Blot S, Bouza E, Brüggemann RJM, Buchheidt D, Cadranel J, Castagnola E, Chakrabarti A, Cuenca-Estrella M, Dimopoulos G, Fortun J, Gangneux JP, Garbino J, Heinz WJ, Herbrecht R, Heussel CP, Kibbler CC, Klimko N, Kullberg BJ, Lange C, Lehrnbecher T, Löffler J, Lortholary O, Maertens J, Marchetti O, Meis JF, Pagano L, Ribaud P, Richardson M, Roilides E, Ruhnke M, Sanguinetti M, Sheppard DC, Sinkó J, Skiada A, Vehreschild MJGT, Viscoli C, Cornely OA
Clin. Microbiol. Infect.. 2018 May;24 Suppl 1:e1-e38
Evaluation of Two Commercial Real-Time PCR Kits for Aspergillus DNA Detection in Bronchoalveolar Lavage Fluid in Patients with Invasive Pulmonary Aspergillosis.
Denis J, Forouzanfar F, Herbrecht R, Toussaint E, Kessler R, Sabou M, Candolfi E, Letsher-Bru V
J Mol Diagn. 2018 May;20(3):298-306
Isavuconazole: A new broad-spectrum azole. Part 1: In vitro activity.
Denis J, Ledoux MP, Nivoix Y, Herbrecht R
J Mycol Med. 2018 Mar;28(1):8-14
Isavuconazole: A new broad-spectrum azole. Part 2: pharmacokinetics and clinical activity.
Ledoux MP, Denis J, Nivoix Y, Herbrecht R
J Mycol Med. 2018 Mar;28(1):15-22
Neutrophils differentially attenuate immune response to Aspergillus infection through complement receptor 3 and induction of myeloperoxidase.
Goh JG, Ravikumar S, Win MS, Cao Q, Tan AL, Lim JHJ, Leong W, Herbrecht R, Troke PF, Kullberg BJ, Netea MG, Chng WJ, Dan YY, Chai LYA
Cell. Microbiol.. 2018 Mar;20(3):
Brain abscesses caused by Cladophialophora bantiana in a lung transplant patient: A case report and review of the literature.
Gschwend A, Dégot T, Denis J, Sabou AM, Jeung MY, Zapata E, Porzio M, Renaud-Picard B, Herbrecht R, Kessler R
Transpl Infect Dis. 2017 Oct;:
History and Outcome of Febrile Neutropenia Outside the Oncology Setting: A Retrospective Study of 76 Cases Related to Non-Chemotherapy Drugs.
Andrès E, Mourot-Cottet R, Maloisel F, Keller O, Vogel T, Séverac F, Tebacher M, Gottenberg JE, Weber JC, Kaltenbach G, Goichot B, Sibilia J, Korganow AS, Herbrecht R
J Clin Med. 2017 Sep;6(10):
FungiScope(™) -Global Emerging Fungal Infection Registry.
Seidel D, Durán Graeff LA, Vehreschild MJGT, Wisplinghoff H, Ziegler M, Vehreschild JJ, Liss B, Hamprecht A, Köhler P, Racil Z, Klimko N, Sheppard DC, Herbrecht R, Chowdhary A, Cornely OA, FungiScope Group
Mycoses. 2017 Aug;60(8):508-516
Simultaneous primary invasive cutaneous aspergillosis in two preterm twins: case report and review of the literature.
Gallais F, Denis J, Koobar O, Dillenseger L, Astruc D, Herbrecht R, Candolfi E, Letscher-Bru V, Sabou M
BMC Infect. Dis.. 2017 Aug;17(1):535
Assessment of high-priced systemic antifungal prescriptions.
Poulat C, Nivoix Y, Launoy A, Lutun P, Bachellier P, Rohr S, Woehl ML, Levêque D, Bru V, Herbrecht R, Gourieux B
Med Mal Infect. 2017 Apr;:
Efficacy of anidulafungin in 539 patients with invasive candidiasis: a patient-level pooled analysis of six clinical trials.
Kullberg BJ, Vasquez J, Mootsikapun P, Nucci M, Paiva JA, Garbino J, Yan JL, Aram J, Capparella MR, Conte U, Schlamm H, Swanson R, Herbrecht R
J. Antimicrob. Chemother.. 2017 Apr;:
(18)F-FDG PET/CT for the Diagnosis of Malignant and Infectious Complications After Solid Organ Transplantation.
Muller N, Kessler R, Caillard S, Epailly E, Hubelé F, Heimburger C, Namer IJ, Herbrecht R, Blondet C, Imperiale A
Nucl Med Mol Imaging. 2017 Mar;51(1):58-68
ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients.
Tissot F, Agrawal S, Pagano L, Petrikkos G, Groll AH, Skiada A, Lass-Flörl C, Calandra T, Viscoli C, Herbrecht R
Haematologica. 2017 Mar;102(3):433-444
New pharmacological opportunities for the treatment of invasive mould diseases.
Ledoux MP, Toussaint E, Denis J, Herbrecht R
J. Antimicrob. Chemother.. 2017 Mar;72(suppl_1):i48-i58
Idiosyncratic drug-induced neutropenia & agranulocytosis.
Andrès E, Mourot-Cottet R, Maloisel F, Séverac F, Keller O, Vogel T, Tebacher M, Weber JC, Kaltenbach G, Gottenberg JE, Goichot B, Sibilia J, Korganow AS, Herbrecht R
QJM. 2017 Jan;:
Idiosyncratic Drug-Induced Severe Neutropenia and Agranulocytosis in Elderly Patients (≥75 years): A Monocentric Cohort Study of 61 Cases.
Mourot-Cottet R, Maloisel F, Séverac F, Keller O, Vogel T, Tebacher M, Weber JC, Kaltenbach G, Gottenberg JE, Goichot B, Sibilia J, Korganow AS, Herbrecht R, Andrès E
Drugs Real World Outcomes. 2016 Dec;3(4):393-399
Early diagnosis and monitoring of mucormycosis by detection of circulating DNA in serum: retrospective analysis of 44 cases collected through the French Surveillance Network of Invasive Fungal Infections (RESSIF).
Millon L, Herbrecht R, Grenouillet F, Morio F, Alanio A, Letscher-Bru V, Cassaing S, Chouaki T, Kauffmann-Lacroix C, Poirier P, Toubas D, Augereau O, Rocchi S, Garcia-Hermoso D, Bretagne S,
Clin. Microbiol. Infect.. 2016 Sep;22(9):810.e1-810.e8
Executive Summary: Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.
Patterson TF, Thompson GR, Denning DW, Fishman JA, Hadley S, Herbrecht R, Kontoyiannis DP, Marr KA, Morrison VA, Nguyen MH, Segal BH, Steinbach WJ, Stevens DA, Walsh TJ, Wingard JR, Young JA, Bennett JE
Clin. Infect. Dis.. 2016 Aug;63(4):433-42
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.
Patterson TF, Thompson GR, Denning DW, Fishman JA, Hadley S, Herbrecht R, Kontoyiannis DP, Marr KA, Morrison VA, Nguyen MH, Segal BH, Steinbach WJ, Stevens DA, Walsh TJ, Wingard JR, Young JA, Bennett JE
Clin. Infect. Dis.. 2016 Aug;63(4):e1-e60
Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis.
Marty FM, Ostrosky-Zeichner L, Cornely OA, Mullane KM, Perfect JR, Thompson GR, Alangaden GJ, Brown JM, Fredricks DN, Heinz WJ, Herbrecht R, Klimko N, Klyasova G, Maertens JA, Melinkeri SR, Oren I, Pappas PG, Ráčil Z, Rahav G, Santos R, Schwartz S, Vehreschild JJ, Young JA, Chetchotisakd P, Jaruratanasirikul S, Kanj SS, Engelhardt M, Kaufhold A, Ito M, Lee M, Sasse C, Maher RM, Zeiher B, Vehreschild MJ,
Lancet Infect Dis. 2016 Jul;16(7):828-37
Multimodality Diagnosis Approach of Cardiac Aspergillosis.
El Ghannudi S, Imperiale A, Dégot T, Germain P, Trinh A, Petean R, Le Van Quyen P, Chenard MP, Letscher-Bru V, Kessler R, Herbrecht R
Echocardiography. 2016 Apr;33(4):663-5
Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial.
Maertens JA, Raad II, Marr KA, Patterson TF, Kontoyiannis DP, Cornely OA, Bow EJ, Rahav G, Neofytos D, Aoun M, Baddley JW, Giladi M, Heinz WJ, Herbrecht R, Hope W, Karthaus M, Lee DG, Lortholary O, Morrison VA, Oren I, Selleslag D, Shoham S, Thompson GR, Lee M, Maher RM, Schmitt-Hoffmann AH, Zeiher B, Ullmann AJ
Lancet. 2016 Feb;387(10020):760-9
Magnetic Resonance Imaging of Cerebral Aspergillosis: Imaging and Pathological Correlations.
Marzolf G, Sabou M, Lannes B, Cotton F, Meyronet D, Galanaud D, Cottier JP, Grand S, Desal H, Kreutz J, Schenck M, Meyer N, Schneider F, Dietemann JL, Koob M, Herbrecht R, Kremer S
PLoS ONE. 2016 ;11(4):e0152475
Anti-pseudo-PCNA type 1 (anti-SG2NA) pattern: Track down Cancer, not SLE.
Guffroy A, Dima A, Nespola B, Poindron V, Sibilia J, Herbrecht R, De Seze J, Habersetzer F, Andres E, Quoix E, Ohlmann P, Cribier B, Langer B, Martin T, Pasquali JL, Goetz J, Korganow AS
Joint Bone Spine. 2015 Sep 30. pii: S1297-319X(15)00151-7
Bing-Neel syndrome, a rare complication of Waldenstrom's macroglobulinemia: analysis of 44 cases and review of the literature. A study on behalf of the French Innovative Leukemia Organization (FILO).
Simon L, Fitsiori A, Lemal R, Dupuis J, Carpentier B, Boudin L, Corby A, Aurran-Schleinitz T, Gastaud L, Talbot A, Lepretre S, Mahe B, Payet C, Soussain C, Bonnet C, Vincent L, Lissandre S, Herbrecht R, Kremer S, Leblond V, Fornecker LM
Haematologica. 2015 Sep 18. pii: haematol.2015.133744.
Longer-term follow-up and outcome by tumour cell proliferation rate (Ki-67) in patients with relapsed/refractory mantle cell lymphoma treated with lenalidomide on MCL-001(EMERGE) pivotal trial.
Goy A, Kalayoglu Besisik S, Drach J, Ramchandren R, Robertson MJ, Avivi I, Rowe JM, Herbrecht R, Van Hoof A, Zhang L, Cicero S, Fu T, Witzig T
Br J Haematol. 2015 Aug;170(4):496-503
Prospective pilot study of high-dose (10 mg/kg/day) liposomal amphotericin B (L-AMB) for the initial treatment of mucormycosis.
Lanternier F, Poiree S, Elie C, Garcia-Hermoso D, Bakouboula P, Sitbon K, Herbrecht R, Wolff M, Ribaud P, Lortholary O
J Antimicrob Chemother. 2015 Aug 27. pii: dkv236.
Economic Comparison of an Empirical Versus Diagnostic-Driven Strategy for Treating Invasive Fungal Disease in Immunocompromised Patients.
Barnes R, Earnshaw S, Herbrecht R, Morrissey O, Slavin M, Bow E, McDade C, Charbonneau C, Weinstein D, Kantecki M, Schlamm H, Maertens J
Clin Ther. 2015 Apr 16. pii: S0149-2918(15)00163-0
Bilberry extract (Antho 50) selectively induces redox-sensitive caspase 3-related apoptosis in chronic lymphocytic leukemia cells by targeting the Bcl-2/Bad pathway.
Alhosin M, León-González AJ, Dandache I, Lelay A, Rashid SK, Kevers C, Pincemail J, Fornecker LM, Mauvieux L, Herbrecht R, Schini-Kerth VB
Sci Rep. 2015 Mar;5:8996
Haemorrhagic and thrombotic diatheses in mouse models with thrombocytosis.
Strassel C, Kubovcakova L, Mangin PH, Ravanat C, Freund M, Skoda RC, Denis CV, Dupuis A, Herbrecht R, Gachet C, Lanza F
Thromb Haemost. 2015 Feb;113(2):414-25
Combination antifungal therapy for invasive aspergillosis: a randomized trial.
Marr KA, Schlamm HT, Herbrecht R, Rottinghaus ST, Bow EJ, Cornely OA, Heinz WJ, Jagannatha S, Koh LP, Kontoyiannis DP, Lee DG, Nucci M, Pappas PG, Slavin MA, Queiroz-Telles F, Selleslag D, Walsh TJ, Wingard JR, Maertens JA
Ann Intern Med. 2015 Jan 20;162(2):81-9
Impact of clinical pharmacy services in a hematology/oncology inpatient setting.
Delpeuch A, Leveque D, Gourieux B, Herbrecht R
Anticancer Res. 2015 Jan;35(1):457-60.
Randomised, multicentre trial of micafungin vs. an institutional standard regimen for salvage treatment of invasive aspergillosis.
Cornely OA, Meems L, Herbrecht R, Viscoli C, van Amsterdam RG, Ruhnke M
Mycoses. 2015 Jan;58(1):58-64
[Erratum to "Medication adverse events: Impact of pharmaceutical consultations during the hospitalization of patients" [Ann. Pharm. Fr. 72 (2014) 440-450].]
Santucci R, Leveque D, Herbrecht R, Fischbach M, Gerout AC, Untereiner C, Bouayad-Agha K, Couturier F
Ann Pharm Fr. 2015 Jan 8. pii: S0003-4509(14)00137-0
Application of the 2008 Definitions for Invasive Fungal Diseases to the Trial Comparing Voriconazole versus Amphotericin B for Therapy of Invasive Aspergillosis. A Collaborative Study of the Mycoses Study Group (MSG 05) and the EORTC Infectious Diseases
Herbrecht R, Patterson TF, Slavin MA, Marchetti O, Maertens J, Johnson EM, Schlamm HT, Donnelly JP, Pappas PG
Clin Infect Dis. 2014 Nov 19. pii: ciu911.
Fatal stimulation of acute myeloid leukemia blasts by pegfilgrastim.
Duval C, Boucher S, Moulin JC, Gourieux B, Mauvieux L, Leveque D, Herbrecht R
Anticancer Res. 2014 Nov;34(11):6747-8.
[Medication adverse events: Impact of pharmaceutical consultations during the hospitalization of patients].
Santucci R, Leveque D, Herbrecht R, Fischbach M, Gerout AC, Untereiner C, Bouayad-Agha K, Couturier F
Ann Pharm Fr. 2014 Nov;72(6):440-50
Improvement in the outcome of invasive fusariosis in the last decade.
Nucci M, Marr KA, Vehreschild MJ, de Souza CA, Velasco E, Cappellano P, Carlesse F, Queiroz-Telles F, Sheppard DC, Kindo A, Cesaro S, Hamerschlak N, Solza C, Heinz WJ, Schaller M, Atalla A, Arikan-Akdagli S, Bertz H, Galvao Castro C Jr, Herbrecht R, Hoenigl M, Harter G, Hermansen NE, Josting A, Pagano L, Salles MJ, Mossad SB, Ogunc D, Pasqualotto AC, Araujo V, Troke PF, Lortholary O, Cornely OA, Anaissie E
Clin Microbiol Infect. 2014 Jun;20(6):580-5
Voriconazole or amphotericin B as primary therapy yields distinct early serum galactomannan trends related to outcomes in invasive aspergillosis.
Chai LY, Kullberg BJ, Earnest A, Johnson EM, Teerenstra S, Vonk AG, Schlamm HT, Herbrecht R, Netea MG, Troke PF
PLoS One. 2014 Feb 28;9(2):e90176
Invasive infections due to Candida norvegensis and Candida inconspicua: report of 12 cases and review of the literature.
Guitard J, Angoulvant A, Letscher-Bru V, L'Ollivier C, Cornet M, Dalle F, Grenouillet F, Lacroix C, Vekhoff A, Maury E, Caillot D, Charles PE, Pili-Floury S, Herbrecht R, Raffoux E, Brethon B, Hennequin C
Med Mycol. 2013 Nov;51(8):795-9
Preventing invasive fungal disease in patients with haematological malignancies and the recipients of haematopoietic stem cell transplantation: practical aspects.
Akan H, Antia VP, Kouba M, Sinko J, Tanase AD, Vrhovac R, Herbrecht R
J Antimicrob Chemother. 2013 Nov;68 3:5-15.
Combined antifungal approach for the treatment of invasive mucormycosis in patients with hematologic diseases: a report from the SEIFEM and FUNGISCOPE registries.
Pagano L, Cornely OA, Busca A, Caira M, Cesaro S, Gasbarrino C, Girmenia C, Heinz WJ, Herbrecht R, Lass-Florl C, Nosari A, Potenza L, Racil Z, Rickerts V, Sheppard DC, Simon A, Ullmann AJ, Valentini CG, Vehreschild JJ, Candoni A, Vehreschild MJ
Haematologica. 2013 Oct;98(10):e127-30
Comparison of pixantrone-based regimen (CPOP-R) with doxorubicin-based therapy (CHOP-R) for treatment of diffuse large B-cell lymphoma.
Herbrecht R, Cernohous P, Engert A, Le Gouill S, Macdonald D, Machida C, Myint H, Saleh A, Singer J, Wilhelm M, van der Jagt R
Ann Oncol. 2013 Oct;24(10):2618-23
High incidence but low burden of coronaviruses and preferential associations between respiratory viruses.
Lepiller Q, Barth H, Lefebvre F, Herbrecht R, Lutz P, Kessler R, Fafi-Kremer S, Stoll-Keller F
J Clin Microbiol. 2013 Sep;51(9):3039-46
Cell-surface expression of the TLR homolog CD180 in circulating cells from splenic and nodal marginal zone lymphomas.
Miguet L, Lennon S, Baseggio L, Traverse-Glehen A, Berger F, Perrusson N, Chenard MP, Galoisy AC, Eischen A, Mayeur-Rousse C, Maar A, Fornecker L, Herbrecht R, Felman P, Van Dorsselaer A, Carapito C, Cianférani S, Mauvieux L
Leukemia. 2013 Aug;27(8):1748-50
An elevated pro-inflammatory cytokine response is linked to development of amphotericin B-induced nephrotoxicity.
Chai LY, Netea MG, Tai BC, Khin LW, Vonk AG, Teo BW, Schlamm HT, Herbrecht R, Donnelly JP, Troke PF, Kullberg BJ
J Antimicrob Chemother. 2013 Jul;68(7):1655-9
A translocation t(2;8)(q12;p11) fuses FGFR1 to a novel partner gene, RANBP2/NUP358, in a myeloproliferative/myelodysplastic neoplasm.
Gervais C, Dano L, Perrusson N, Helias C, Jeandidier E, Galoisy AC, Ittel A, Herbrecht R, Bilger K, Mauvieux L
Leukemia. 2013 Apr;27(5):1186-8
Diagnosis and treatment of mucormycosis in patients with hematological malignancies: guidelines from the 3rd European Conference on Infections in Leukemia (ECIL 3).
Skiada A, Lanternier F, Groll AH, Pagano L, Zimmerli S, Herbrecht R, Lortholary O, Petrikkos GL
Haematologica. 2013 Apr;98(4):492-504
Clinical and radiological aspects of mucormycosis.
Herbrecht R, Sabou M, Ledoux MP
Med Sci (Paris). 2013 Mar;29 Spec No 1:19-24
Biclonal and biallelic deletions occur in 20% of B-ALL cases with IKZF1 mutations.
Dupuis A, Gaub MP, Legrain M, Drenou B, Mauvieux L, Lutz P, Herbrecht R, Chan S, Kastner P
Leukemia. 2013 Feb;27(2):503-7
Function of Ikaros as a tumor suppressor in B cell acute lymphoblastic leukemia.
Kastner P, Dupuis A, Gaub MP, Herbrecht R, Lutz P, Chan S
Am J Blood Res. 2013;3(1):1-13
Severe methotrexate toxicity due to a concomitant administration of ciprofloxacin.
Jarfaut A, Santucci R, Leveque D, Herbrecht R
Med Mal Infect. 2013 Jan;43(1):39-41
Disseminated Trichosporon mycotoxinivorans, Aspergillus fumigatus, and Scedosporium apiospermum coinfection after lung and liver transplantation in a cystic fibrosis patient.
Hirschi S, Letscher-Bru V, Pottecher J, Lannes B, Jeung MY, Degot T, Santelmo N, Sabou AM, Herbrecht R, Kessler R
J Clin Microbiol. 2012 Dec;50(12):4168-70
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT).
Ullmann AJ, Akova M, Herbrecht R, Viscoli C, Arendrup MC, Arikan-Akdagli S, Bassetti M, Bille J, Calandra T, Castagnola E, Cornely OA, Donnelly JP, Garbino J, Groll AH, Hope WW, Jensen HE, Kullberg BJ, Lass-Florl C, Lortholary O, Meersseman W, Petrikkos G, Richardson MD, Roilides E, Verweij PE, Cuenca-Estrella M
Clin Microbiol Infect. 2012 Dec;18 Suppl 7:53-67
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: developing European guidelines in clinical microbiology and infectious diseases.
Ullmann AJ, Cornely OA, Donnelly JP, Akova M, Arendrup MC, Arikan-Akdagli S, Bassetti M, Bille J, Calandra T, Castagnola E, Garbino J, Groll AH, Herbrecht R, Hope WW, Jensen HE, Kullberg BJ, Lass-Florl C, Lortholary O, Meersseman W, Petrikkos G, Richardson MD, Roilides E, Verweij PE, Viscoli C, Cuenca-Estrella M
Clin Microbiol Infect. 2012 Dec;18 Suppl 7:1-8
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients.
Cornely OA, Bassetti M, Calandra T, Garbino J, Kullberg BJ, Lortholary O, Meersseman W, Akova M, Arendrup MC, Arikan-Akdagli S, Bille J, Castagnola E, Cuenca-Estrella M, Donnelly JP, Groll AH, Herbrecht R, Hope WW, Jensen HE, Lass-Florl C, Petrikkos G, Richardson MD, Roilides E, Verweij PE, Viscoli C, Ullmann AJ
Clin Microbiol Infect. 2012 Dec;18 Suppl 7:19-37
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: patients with HIV infection or AIDS.
Lortholary O, Petrikkos G, Akova M, Arendrup MC, Arikan-Akdagli S, Bassetti M, Bille J, Calandra T, Castagnola E, Cornely OA, Cuenca-Estrella M, Donnelly JP, Garbino J, Groll AH, Herbrecht R, Hope WW, Jensen HE, Kullberg BJ, Lass-Florl C, Meersseman W, Richardson MD, Roilides E, Verweij PE, Viscoli C, Ullmann AJ
Clin Microbiol Infect. 2012 Dec;18 Suppl 7:68-77
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp.
Hope WW, Castagnola E, Groll AH, Roilides E, Akova M, Arendrup MC, Arikan-Akdagli S, Bassetti M, Bille J, Cornely OA, Cuenca-Estrella M, Donnelly JP, Garbino J, Herbrecht R, Jensen HE, Kullberg BJ, Lass-Florl C, Lortholary O, Meersseman W, Petrikkos G, Richardson MD, Verweij PE, Viscoli C, Ullmann AJ
Clin Microbiol Infect. 2012 Dec;18 Suppl 7:38-52
Indications and outcomes of antifungal therapy in French patients with haematological conditions or recipients of haematopoietic stem cell transplantation.
Herbrecht R, Caillot D, Cordonnier C, Auvrignon A, Thiebaut A, Brethon B, Michallet M, Mahlaoui N, Bertrand Y, Preziosi P, Ruiz F, Gorin NC, Gangneux JP
J Antimicrob Chemother. 2012 Nov;67(11):2731-8
Adherence to recommendations for the use of antifungal agents in a tertiary care hospital.
Nivoix Y, Launoy A, Lutun P, Moulin JC, Phai Pang KA, Fornecker LM, Wolf M, Leveque D, Letscher-Bru V, Beretz L, Ubeaud-Sequier G, Herbrecht R
J Antimicrob Chemother. 2012 Oct;67(10):2506-13
Bendamustine compared with chlorambucil in previously untreated patients with chronic lymphocytic leukaemia: updated results of a randomized phase III trial.
Knauf WU, Lissitchkov T, Aldaoud A, Liberati AM, Loscertales J, Herbrecht R, Juliusson G, Postner G, Gercheva L, Goranov S, Becker M, Fricke HJ, Huguet F, Del Giudice I, Klein P, Merkle K, Montillo M
Br J Haematol. 2012 Oct;159(1):67-77
Mucormycosis after allogeneic haematopoietic stem cell transplantation: a French Multicentre Cohort Study (2003-2008).
Xhaard A, Lanternier F, Porcher R, Dannaoui E, Bergeron A, Clement L, Lacroix C, Herbrecht R, Legrand F, Mohty M, Michallet M, Cordonnier C, Malak S, Guyotat D, Couderc LJ, Socie G, Milpied N, Lortholary O, Ribaud P
Clin Microbiol Infect. 2012 Oct;18(10):E396-400
Early serum galactomannan trend as a predictor of outcome of invasive aspergillosis.
Chai LY, Kullberg BJ, Johnson EM, Teerenstra S, Khin LW, Vonk AG, Maertens J, Lortholary O, Donnelly PJ, Schlamm HT, Troke PF, Netea MG, Herbrecht R
J Clin Microbiol. 2012 Jul;50(7):2330-6
Breakthrough invasive mould infections in patients treated with caspofungin.
Pang KA, Godet C, Fekkar A, Scholler J, Nivoix Y, Letscher-Bru V, Massias L, Kauffmann-Lacroix C, Elsendoorn A, Uzunov M, Datry A, Herbrecht R
J Infect. 2012 Apr;64(4):424-9
Earlier diagnosis of angioinvasive pulmonary mold disease: is computed tomography pulmonary angiography a new step?
Herbrecht R, Roedlich MN
Clin Infect Dis. 2012 Mar 1;54(5):617-20
Febrile pancytopenia as uncommon presentation of disseminated toxoplasmosis after BMT.
Bories P, Zink E, Mattern JF, Villard O, Berceanu A, Bilger K, Candolfi E, Herbrecht R, Abou-Bacar A, Lioure B
Bone Marrow Transplant. 2012 Feb;47(2):301-3
Waldenstrom's macroglobulinemia harbors a unique proteome where Ku70 is severely underexpressed as compared with other B-lymphoproliferative disorders.
Perrot A, Pionneau C, Azar N, Baillou C, Lemoine FM, Leblond V, Merle-Beral H, Bene MC, Herbrecht R, Bahram S, Vallat L
Blood Cancer J. 2012 Sep 7;2:e88
Ventricular bigeminy associated with voriconazole, methadone and esomeprazole.
Scholler J, Nivoix Y, Herbrecht R, Kemmel V, Leveque D
Int J Clin Pharm. 2011 Dec;33(6):905-8
Pharmacokinetic drug-drug interactions with methotrexate in oncology.
Leveque D, Santucci R, Gourieux B, Herbrecht R
Expert Rev Clin Pharmacol. 2011 Nov;4(6):743-50.
Efficacy outcomes in a randomised trial of liposomal amphotericin B based on revised EORTC/MSG 2008 definitions of invasive mould disease.
Cornely OA, Maertens J, Bresnik M, Ebrahimi R, Dellow E, Herbrecht R, Donnelly JP
Mycoses. 2011 Sep;54(5):e449-55
European expert opinion on the management of invasive candidiasis in adults.
Kullberg BJ, Verweij PE, Akova M, Arendrup MC, Bille J, Calandra T, Cuenca-Estrella M, Herbrecht R, Jacobs F, Kalin M, Kibbler CC, Lortholary O, Martino P, Meis JF, Munoz P, Odds FC, De Pauw BE, Rex JH, Roilides E, Rogers TR, Ruhnke M, Ullmann AJ, Uzun O, Vandewoude K, Vincent JL, Donnelly JP
Clin Microbiol Infect. 2011 Sep;17 Suppl 5:1-12
Survival impact of rituximab combined with ACVBP and upfront consolidation autotransplantation in high-risk diffuse large B-cell lymphoma for GELA.
Fitoussi O, Belhadj K, Mounier N, Parrens M, Tilly H, Salles G, Feugier P, Ferme C, Ysebaert L, Gabarre J, Herbrecht R, Janvier M, Van Den Neste E, Morschhauser F, Casasnovas O, Ghesquieres H, Anglaret B, Brechignac S, Haioun C, Gisselbrecht C
Haematologica. 2011 Aug;96(8):1136-43
A unique proteomic profile on surface IgM ligation in unmutated chronic lymphocytic leukemia.
Perrot A, Pionneau C, Nadaud S, Davi F, Leblond V, Jacob F, Merle-Beral H, Herbrecht R, Bene MC, Gribben JG, Bahram S, Vallat L
Blood. 2011 Jul 28;118(4):e1-15
European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3--2009 update.
Maertens J, Marchetti O, Herbrecht R, Cornely OA, Fluckiger U, Frere P, Gachot B, Heinz WJ, Lass-Florl C, Ribaud P, Thiebaut A, Cordonnier C
Bone Marrow Transplant. 2011 May;46(5):709-18
A retrospective series of gut aspergillosis in haematology patients.
Kazan E, Maertens J, Herbrecht R, Weisser M, Gachot B, Vekhoff A, Caillot D, Raffoux E, Fagot T, Reman O, Isnard F, Thiebaut A, Bretagne S, Cordonnier C
Clin Microbiol Infect. 2011 Apr;17(4):588-94
Phase I/II study of pixantrone in combination with cyclophosphamide, vincristine, and prednisone in patients with relapsed aggressive non-Hodgkin lymphoma.
Borchmann P, Herbrecht R, Wilhelm M, Morschhauser F, Hess G, Cernohous P, Veals SA, Singer JW, Engert A
Leuk Lymphoma. 2011 Apr;52(4):620-8.
[Potential clinical impact of therapeutic education in patients treated with anticancer drugs].
Santucci R, Aatmani AE, Lescoute A, Leveque D, Serra S, Bergerat JP, Beretz L, Herbrecht R
Bull Cancer. 2011 Feb 1;98(2):176-81.
Cost effectiveness of posaconazole in the prophylaxis of invasive fungal infections in acute leukaemia patients for the French healthcare system.
Michallet M, Gangneux JP, Lafuma A, Herbrecht R, Ribaud P, Caillot D, Dupont B, Moreau P, Berger P, O'Sullivan AK
J Med Econ. 2011;14(1):28-35
Risk assessment and prognostic factors for mould-related diseases in immunocompromised patients.
Pagano L, Akova M, Dimopoulos G, Herbrecht R, Drgona L, Blijlevens N
J Antimicrob Chemother. 2011 Jan;66 Suppl 1:i5-14.
Systematic review and mixed treatment comparison of randomized evidence for empirical, pre-emptive and directed treatment strategies for invasive mould disease.
Freemantle N, Tharmanathan P, Herbrecht R
J Antimicrob Chemother. 2011 Jan;66 Suppl 1:i25-35.
Towards novel paradigms for cancer therapy.
Pavet V, Portal MM, Moulin JC, Herbrecht R, Gronemeyer H
Oncogene. 2011 Jan 6;30(1):1-20
Cola beverage and delayed elimination of methotrexate.
Santucci R, Leveque D, Herbrecht R
Br J Clin Pharmacol. 2010 Nov;70(5):762-4.
Cola beverage and delayed elimination of methotrexate.
Santucci R, Leveque D, Herbrecht R
Br J Clin Pharmacol. 2010 Nov;70(5):762-4
Early proinflammatory cytokines and C-reactive protein trends as predictors of outcome in invasive Aspergillosis.
Chai LA, Netea MG, Teerenstra S, Earnest A, Vonk AG, Schlamm HT, Herbrecht R, Troke PF, Kullberg BJ
J Infect Dis. 2010 Nov 1;202(9):1454-62.
Comparative survival and cost of antifungal therapy: posaconazole versus standard antifungals in the treatment of refractory invasive aspergillosis.
Herbrecht R, Rajagopalan S, Danna R, Papadopoulos G
Curr Med Res Opin. 2010 Oct;26(10):2457-64.
International retrospective analysis of 73 cases of invasive fusariosis treated with voriconazole.
Lortholary O, Obenga G, Biswas P, Caillot D, Chachaty E, Bienvenu AL, Cornet M, Greene J, Herbrecht R, Lacroix C, Grenouillet F, Raad I, Sitbon K, Troke P
Antimicrob Agents Chemother. 2010 Oct;54(10):4446-50
Delayed elimination of methotrexate associated with co-administration of proton pump inhibitors.
Santucci R, Leveque D, Lescoute A, Kemmel V, Herbrecht R
Anticancer Res. 2010 Sep;30(9):3807-10.
Caspofungin first-line therapy for invasive aspergillosis in allogeneic hematopoietic stem cell transplant patients: an European Organisation for Research and Treatment of Cancer study.
Herbrecht R, Maertens J, Baila L, Aoun M, Heinz W, Martino R, Schwartz S, Ullmann AJ, Meert L, Paesmans M, Marchetti O, Akan H, Ameye L, Shivaprakash M, Viscoli C
Bone Marrow Transplant. 2010 Jul;45(7):1227-33
Computer tomography in pulmonary invasive aspergillosis in hematological patients with neutropenia: an useful tool for diagnosis and assessment of outcome in clinical trials.
Caillot D, Latrabe V, Thiebaut A, Herbrecht R, De Botton S, Pigneux A, Monchecourt F, Mahi L, Alfandari S, Couaillier JF
Eur J Radiol. 2010 Jun;74(3):e172-5
Severe Intoxication with Methotrexate Possibly Associated with Concomitant Use of Proton Pump Inhibitors
Santucci R, Leveque D, Kemmel V, Lutz P, Gerout AC, N'guyen A, Lescoute A, Schneider F, Bergerat JP, Herbrecht R
Anticancer Res. 2010 Mar;30(3):963-5.
Forty-one recent cases of invasive zygomycosis from a global clinical registry.
Ruping MJ, Heinz WJ, Kindo AJ, Rickerts V, Lass-Florl C, Beisel C, Herbrecht R, Roth Y, Silling G, Ullmann AJ, Borchert K, Egerer G, Maertens J, Maschmeyer G, Simon A, Wattad M, Fischer G, Vehreschild JJ, Cornely OA
J Antimicrob Chemother. 2010 Feb;65(2):296-302
Lessons from a case of oromandibular mucormycosis treated with surgery and a combination of amphotericin B lipid formulation plus caspofungin.
Ojeda-Uribe M, Herbrecht R, Kiefer MH, Schultz P, Chain J, Chenard MP, Servant JM, Debry C
Acta Haematol. 2010;124(2):98-102
Successful treatment of a granulocytic sarcoma of the uterine cervix in complete remission at six-year follow-up.
Kim SC, Natarajan-Ame S, Lioure B, Chenard MP, Duclos B, Herbrecht R, Bergerat JP
J Oncol. 2010;2010:812424
Treatment outcome of invasive mould disease after sequential exposure to azoles and liposomal amphotericin B.
Cornely OA, Maertens J, Bresnik M, Ullmann AJ, Ebrahimi R, Herbrecht R
J Antimicrob Chemother. 2010 Jan;65(1):114-7
An EORTC Phase II study of caspofungin as first-line therapy of invasive aspergillosis in haematological patients.
Viscoli C, Herbrecht R, Akan H, Baila L, Sonet A, Gallamini A, Giagounidis A, Marchetti O, Martino R, Meert L, Paesmans M, Ameye L, Shivaprakash M, Ullmann AJ, Maertens J
J Antimicrob Chemother. 2009 Dec;64(6):1274-81
Association of mannose-binding lectin deficiency with acute invasive aspergillosis in immunocompromised patients.
Lambourne J, Agranoff D, Herbrecht R, Troke PF, Buchbinder A, Willis F, Letscher-Bru V, Agrawal S, Doffman S, Johnson E, White PL, Barnes RA, Griffin G, Lindsay JA, Harrison TS
Clin Infect Dis. 2009 Nov 15;49(10):1486-91.
Phase III randomized study of bendamustine compared with chlorambucil in previously untreated patients with chronic lymphocytic leukemia.
Knauf WU, Lissichkov T, Aldaoud A, Liberati A, Loscertales J, Herbrecht R, Juliusson G, Postner G, Gercheva L, Goranov S, Becker M, Fricke HJ, Huguet F, Del Giudice I, Klein P, Tremmel L, Merkle K, Montillo M
J Clin Oncol. 2009 Sep 10;27(26):4378-84
Proteomic analysis of malignant B-cell derived microparticles reveals CD148 as a potentially useful antigenic biomarker for mantle cell lymphoma diagnosis.
Miguet L, Bechade G, Fornecker L, Zink E, Felden C, Gervais C, Herbrecht R, van Dorsselaer A, Mauvieux L, Sanglier-Cianferani S
J Proteome Res. 2009 Jul;8(7):3346-54.
A Multicenter, double-blind trial of a high-dose caspofungin treatment regimen versus a standard caspofungin treatment regimen for adult patients with invasive candidiasis.
Betts RF, Nucci M, Talwar D, Gareca M, Queiroz-Telles F, Bedimo RJ, Herbrecht R, Ruiz-Palacios G, Young JA, Baddley JW, Strohmaier KM, Tucker KA, Taylor AF, Kartsonis NA
Clin Infect Dis. 2009 Jun 15;48(12):1676-84.
Drug-Drug Interactions of Triazole Antifungal Agents in Multimorbid Patients and Implications for Patient Care
Nivoix Y, Ubeaud-Sequier G, Engel P, Leveque D, Herbrecht R
Curr Drug Metab. 2009 May;10(4):395-409.
Stimulation of B-cell lymphoproliferations with CpG-oligonucleotide DSP30 plus IL-2 is more effective than with TPA to detect clonal abnormalities.
Struski S, Gervais C, Helias C, Herbrecht R, Audhuy B, Mauvieux L
Leukemia. 2009 Mar;23(3):617-9
Factors associated with overall and attributable mortality in invasive aspergillosis.
Nivoix Y, Velten M, Letscher-Bru V, Moghaddam A, Natarajan-Ame S, Fohrer C, Lioure B, Bilger K, Lutun P, Marcellin L, Launoy A, Freys G, Bergerat JP, Herbrecht R
Clin Infect Dis. 2008 Nov 1;47(9):1176-84
Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria.
Segal BH, Herbrecht R, Stevens DA, Ostrosky-Zeichner L, Sobel J, Viscoli C, Walsh TJ, Maertens J, Patterson TF, Perfect JR, Dupont B, Wingard JR, Calandra T, Kauffman CA, Graybill JR, Baden LR, Pappas PG, Bennett JE, Kontoyiannis DP, Cordonnier C, Viviani MA, Bille J, Almyroudis NG, Wheat LJ, Graninger W, Bow EJ, Holland SM, Kullberg BJ, Dismukes WE, De Pauw BE
Clin Infect Dis. 2008 Sep 1;47(5):674-83.
Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) C
De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, Pappas PG, Maertens J, Lortholary O, Kauffman CA, Denning DW, Patterson TF, Maschmeyer G, Bille J, Dismukes WE, Herbrecht R, Hope WW, Kibbler CC, Kullberg BJ, Marr KA, Munoz P, Odds FC, Perfect JR, Restrepo A, Ruhnke M, Segal BH, Sobel JD, Sorrell TC, Viscoli C, Wingard JR, Zaoutis T, Bennett JE
Clin Infect Dis. 2008 Jun 15;46(12):1813-21.
Changes in causes of death over time after treatment for invasive aspergillosis
Wingard JR, Ribaud P, Schlarri HT, Herbrecht R
Cancer. 2008 May 15;112(10):2309-12.
Beta-D-glucan detection test: a step toward preemptive therapy for fungal infections in leukemic patients?
Herbrecht R, Berceanu A
Clin Infect Dis. 2008 Mar 15;46(6):886-9.
Treatment of aspergillosis: Clinical practice guidelines of the infectious diseases society of America
Walsh TJ, Anaissie EJ, Denning DW, Herbrecht R, Kontoyiannis DP, Marr KA, Morrison VA, Segal BH, Steinbach WJ, Stevens DA, van Burik JA, Wingard JR, Patterson TF
Clin Infect Dis. 2008 Feb 1;46(3):327-60.
Polycythemia vera transforming to acute myeloid leukemia and complex abnormalities including 9p homogeneously staining region with amplification of MLLT3, JMJD2C, JAK2, and SMARCA2.
Helias C, Struski S, Gervais C, Leymarie V, Mauvieux L, Herbrecht R, Lessard M
Cancer Genet Cytogenet. 2008 Jan 1;180(1):51-5.
The Enzymatic Basis of Drug-Drug Interactions with Systemic Triazole Antifungals
Nivoix Y, Leveque D, Herbrecht R, Koffel JC, Beretz L, Ubeaud-Sequier G
Clin Pharmacokinet. 2008;47(12):779-92
Liposomal amphotericin B in combination with caspofungin for invasive aspergillosis in patients with hematologic malignancies: a randomized pilot study (Combistrat trial).
Caillot D, Thiebaut A, Herbrecht R, de Botton S, Pigneux A, Bernard F, Larche J, Monchecourt F, Alfandari S, Mahi L
Cancer. 2007 Dec 15;110(12):2740-6.
Resource use and cost of treatment with voriconazole or conventional amphotericin B for invasive aspergillosis.
Wingard JR, Herbrecht R, Mauskopf J, Schlamm HT, Marciniak A, Roberts CS
Transpl Infect Dis. 2007 Sep;9(3):182-8
Treatment of invasive Candida and invasive Aspergillus infections in adult haematological patients.
Herbrecht R, Fluckiger U, Gachot B, Ribaud P, Thiebaut A, Cordonnier C
Ejc Suppl. 2007 Jul;5(2):49-59.
[F-18]fluoro-2-deoxy-D-glucose positron emission tomography computed tomography for early evaluation of treatment efficacy in advanced non-Hodgkin lymphoma of uterine corpus: A case report
Imperiale A, Blondet C, Fohrer C, Cimarelli S, Herbrecht R, Constantinesco A
Clin Lymphoma Myeloma. 2007 May;7(6):421-4.
13q deletions in B-cell lymphoproliferative disorders: frequent association with translocation.
Struski S, Helias C, Gervais C, Audhuy B, Zamfir A, Herbrecht R, Lessard M
Cancer Genet Cytogenet. 2007 Apr 15;174(2):151-60.
Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo sign.
Greene RE, Schlamm HT, Oestmann JW, Stark P, Durand C, Lortholary O, Wingard JR, Herbrecht R, Ribaud P, Patterson TF, Troke PF, Denning DW, Bennett JE, de Pauw BE, Rubin RH
Clin Infect Dis. 2007 Feb 1;44(3):373-9
[A cytological, immunophenotypical and cytogenetical study of 136 consecutive cases of B-cell chronic lymphoid hemopathies]
Struski S, Leymarie V, Helias C, Falkenrodt A, Fohrer C, Audhuy B, Lioure B, Moskovtchenko P, Mazurier I, Galoisy AC, Gervais C, Mauvieux L, Herbrecht R, Bergerat JP, Lessard M
Pathol Biol (Paris). 2007 Feb;55(1):59-72
HDAC inhibitors induce apoptosis in glucocorticoid-resistant acute lymphatic leukemia cells despite a switch from the extrinsic to the intrinsic death pathway.
Tsapis M, Lieb M, Manzo F, Shankaranarayanan P, Herbrecht R, Lutz P, Gronemeyer H
Int J Biochem Cell Biol. 2007;39(7-8):1500-9
Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial.
Walsh TJ, Raad I, Patterson TF, Chandrasekar P, Donowitz GR, Graybill R, Greene RE, Hachem R, Hadley S, Herbrecht R, Langston A, Louie A, Ribaud P, Segal BH, Stevens DA, van Burik JA, White CS, Corcoran G, Gogate J, Krishna G, Pedicone L, Hardalo C, Perfect JR
Clin Infect Dis. 2007 Jan 1;44(1):2-12
Multicenter, noncomparative study of caspofungin in combination with other antifungals as salvage therapy in adults with invasive aspergillosis.
Maertens J, Glasmacher A, Herbrecht R, Thiebaut A, Cordonnier C, Segal BH, Killar J, Taylor A, Kartsonis N, Patterson TF, Aoun M, Caillot D, Sable C
Cancer. 2006 Dec 15;107(12):2888-97.
Mycograb for the treatment of invasive candidiasis.
Herbrecht R, Fohrer C, Nivoix Y
Clin Infect Dis. 2006 Oct 15;43(8):1083; author reply 1083-4.
Clinical antifungal efficacy trials in invasive aspergillosils: Consensus standards for trial design and room for improvement.
Nivoix Y, Fohrer C, Fornecker L, Herbrecht R
. 2006 Sep;44 1:S289-94.
Discovery and identification of potential biomarkers in a prospective study of chronic lymphoid malignancies using SELDI-TOF-MS.
Miguet L, Bogumil R, Decloquement P, Herbrecht R, Potier N, Mauvieux L, Van Dorsselaer A
J Proteome Res. 2006 Sep;5(9):2258-69.
EXTEND PIX301: a phase III randomized trial of pixantrone versus other chemotherapeutic agents as third-line monotherapy in patients with relapsed, aggressive non-Hodgkin's lymphoma.
Engert A, Herbrecht R, Santoro A, Zinzani PL, Gorbatchevsky I
Clin Lymphoma Myeloma. 2006 Sep;7(2):152-4.
Long-term survival in post-transplant lymphoproliferative disorders with a dose-adjusted ACVBP regimen.
Fohrer C, Caillard S, Koumarianou A, Ellero B, Woehl-Jaegle ML, Meyer C, Epailly E, Chenard MP, Lioure B, Natarajan-Ame S, Maloisel F, Lutun P, Kessler R, Moulin B, Bergerat JP, Wolf P, Herbrecht R
Br J Haematol. 2006 Sep;134(6):602-12
Cytogenetic studies of a series of 43 consecutive secondary myelodysplastic syndromes/acute myeloid leukemias: conventional cytogenetics, FISH, and multiplex FISH.
Shali W, Helias C, Fohrer C, Struski S, Gervais C, Falkenrodt A, Leymarie V, Lioure B, Raby P, Herbrecht R, Lessard M
Cancer Genet Cytogenet. 2006 Jul 15;168(2):133-45.
Antifungal combination treatment: a future perspective.
Fohrer C, Fornecker L, Nivoix Y, Cornila C, Marinescu C, Herbrecht R
Int J Antimicrob Agents. 2006 Jun;27 Suppl 1:25-30
Clinical pharmacokinetics of voriconazole.
Leveque D, Nivoix Y, Jehl F, Herbrecht R
Int J Antimicrob Agents. 2006 Apr;27(4):274-84
Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: results of a prospective multicenter phase 2 study.
Choquet S, Leblond V, Herbrecht R, Socie G, Stoppa AM, Vandenberghe P, Fischer A, Morschhauser F, Salles G, Feremans W, Vilmer E, Peraldi MN, Lang P, Lebranchu Y, Oksenhendler E, Garnier JL, Lamy T, Jaccard A, Ferrant A, Offner F, Hermine O, Moreau A, Fafi-Kremer S, Morand P, Chatenoud L, Berriot-Varoqueaux N, Bergougnoux L, Milpied N
Blood. 2006 Apr 15;107(8):3053-7
Prognostic factors for death due to invasive aspergillosis after hematopoietic stem cell transplantation: a 1-year retrospective study of consecutive patients at French transplantation centers.
Cordonnier C, Ribaud P, Herbrecht R, Milpied N, Valteau-Couanet D, Morgan C, Wade A
Clin Infect Dis. 2006 Apr 1;42(7):955-63
Combination of caspofungin and an azole or an amphotericin B formulation in invasive fungal infections.
Nivoix Y, Zamfir A, Lutun P, Kara F, Remy V, Lioure B, Rigolot JC, Entz-Werle N, Letscher-Bru V, Waller J, Leveque D, Koffel JC, Beretz L, Herbrecht R
J Infect. 2006 Jan;52(1):67-74.
Posaconazole as salvage therapy for zygomycosis.
Greenberg RN, Mullane K, van Burik JA, Raad I, Abzug MJ, Anstead G, Herbrecht R, Langston A, Marr KA, Schiller G, Schuster M, Wingard JR, Gonzalez CE, Revankar SG, Corcoran G, Kryscio RJ, Hare R
Antimicrob Agents Chemother. 2006 Jan;50(1):126-33.
Proteomic analysis of malignant lymphocyte membrane microparticles using double ionization coverage optimization.
Miguet L, Pacaud K, Felden C, Hugel B, Martinez MC, Freyssinet JM, Herbrecht R, Potier N, van Dorsselaer A, Mauvieux L
Proteomics. 2006 Jan;6(1):153-71.
Strategy of following voriconazole versus amphotericin B therapy with other licensed antifungal therapy for primary treatment of invasive aspergillosis: impact of other therapies on outcome.
Patterson TF, Boucher HW, Herbrecht R, Denning DW, Lortholary O, Ribaud P, Rubin RH, Wingard JR, DePauw B, Schlamm HT, Troke P, Bennett JE
Clin Infect Dis. 2005 Nov 15;41(10):1448-52
Risk factors for Gram-negative bacterial infections in febrile neutropenia.
Cordonnier C, Herbrecht R, Buzyn A, Leverger G, Leclercq R, Nitenberg G, Bastuji-Garin S
Haematologica. 2005 Aug;90(8):1102-9.
Epidemiological study of invasive pulmonary aspergillosis in a haematology unit by molecular typing of environmental and patient isolates of Aspergillus fumigatus.
Menotti J, Waller J, Meunier O, Letscher-Bru V, Herbrecht R, Candolfi E
J Hosp Infect. 2005 May;60(1):61-8.
Invasive aspergillosis in the hematologic and immunologic patient: new findings and key questions in leukemia.
Herbrecht R, Moghaddam A, Mahmal L, Natarajan-Ame S, Fornecker LM, Letscher-Bru V
Med Mycol. 2005 May;43 Suppl 1:S239-42.
Can combination salvage therapy for invasive aspergillosis improve patient outcome?
Herbrecht R, Natarajan-Ame S
Nat Clin Pract Oncol. 2005 Apr;2(4):186-7.
Voriconazole for invasive bone aspergillosis: a worldwide experience of 20 cases.
Mouas H, Lutsar I, Dupont B, Fain O, Herbrecht R, Lescure FX, Lortholary O
Clin Infect Dis. 2005 Apr 15;40(8):1141-7
Efficacy and safety of rasburicase (recombinant urate oxidase) for the prevention and treatment of hyperuricemia during induction chemotherapy of aggressive non-Hodgkin's lymphoma: results of the GRAAL1 (Groupe d'Etude des Lymphomes de l'Adulte Trial on R
Coiffier B, Mounier N, Bologna S, Ferme C, Tilly H, Sonet A, Christian B, Casasnovas O, Jourdan E, Belhadj K, Herbrecht R
J Clin Oncol. 2003 Dec 1;21(23):4402-6
Cefepime/amikacin versus ceftazidime/amikacin as empirical therapy for febrile episodes in neutropenic patients: a comparative study. The French Cefepime Study Group.
Cordonnier C, Herbrecht R, Pico JL, Gardembas M, Delmer A, Delain M, Moreau P, Ladeb S, Nalet V, Rollin C, Gres JJ
Clin. Infect. Dis.. 1997 Jan;24(1):41-51
